Preferred Label : sulfones;

MeSH synonym : Sulfone;

Wikipedia link : https://en.wikipedia.org/wiki/Sulfone;

Is substance : O;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3244195/fr/zykadia-cbnpc
2021
false
false
false
France
insurance, health, reimbursement
treatment outcome
antineoplastic agents
protein kinase inhibitors
receptor Protein-Tyrosine kinases
ceritinib
administration, oral
bronchial neoplasms
carcinoma, non-small-cell lung
ALK gene rearrangement positive
Tyrosine Kinase Inhibitors
evaluation of the transparency committee
ceritinib
pyrimidines
sulfones
pyrimidines
sulfones

---
https://www.inrs.fr/media.html?refINRS=TF%20277
2020
France
journal article
paper
skin, nos
bis(4-hydroxyphenyl)sulfone
Exhibition
effects of exposure to external cause, nos
paper, nos
phenols
sulfones

---
Impregnation of the French population by bisphenols A, S and F. National Biomonitoring Program, Esteban 2014-2016
https://www.santepubliquefrance.fr/determinants-de-sante/exposition-a-des-substances-chimiques/perturbateurs-endocriniens/documents/rapport-synthese/impregnation-de-la-population-francaise-par-les-bisphenols-a-s-et-f-programme-national-de-biosurveillance-esteban-2014-2016
2019
false
false
false
France
bisphenol A
bis(4-hydroxyphenyl)sulfone
france
environmental exposure
hazard surveillance program
bis(4-hydroxyphenyl)sulfone
bisphenol A
bisphenol B
adult
child
technical report
population
biosurveillance
bisphenol F
benzhydryl compounds
phenols
safety management
benzhydryl compounds
phenols
sulfones
phenols
sulfones
benzhydryl compounds

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00383
2018
false
false
false
Canada
French
English
drug information
lifitegrast
drug evaluation
drug approval
canada
lymphocyte Function-Associated Antigen-1
dry eye syndromes
adult
aged
administration, ophthalmic
ophthalmic solutions
treatment outcome
risk assessment
lifitegrast
product surveillance, postmarketing
lifitegrast
sulfones
phenylalanine
sulfones
phenylalanine
phenylalanine
sulfones
phenylalanine

---
https://www.has-sante.fr/portail/jcms/c_2888462/fr/zykadia
2018
false
false
false
France
administration, oral
evaluation of the transparency committee
Zykadia
ceritinib
pyrimidines
sulfones

---
https://www.has-sante.fr/portail/jcms/c_2887771/fr/zykadia
2018
false
false
false
France
evaluation of the transparency committee
Zykadia
ceritinib
pyrimidines
sulfones

---
https://ansm.sante.fr/informations-de-securite/ceritinib-zykadia-r-150-mg-gelule-nouvelle-posologie-recommandee-dinitiation-du-traitement
2018
false
false
false
France
French
guidelines for drug use
pharmacovigilance note
administration, oral
ceritinib
patient education handout
antineoplastic agents
carcinoma, non-small-cell lung
ceritinib
product surveillance, postmarketing
pyrimidines
sulfones

---
https://www.has-sante.fr/portail/jcms/c_2824816/fr/zykadia
https://www.has-sante.fr/portail/jcms/c_2824816/fr/zykadia-ceritinib-inhibiteur-de-tyrosine-kinase
2017
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
administration, oral
ceritinib
ceritinib
ceritinib
adult
Advanced Malignant Neoplasm
carcinoma, non-small-cell lung
carcinoma, non-small-cell lung
ALK gene rearrangement positive
insurance, health, reimbursement
protein kinase inhibitors
protein kinase inhibitors
antineoplastic agents
antineoplastic agents
protein-tyrosine kinases
survival analysis
guidelines for drug use
Tyrosine Kinase Inhibitors
pyrimidines
sulfones
pyrimidines
sulfones
receptor Protein-Tyrosine kinases
Anaplastic Lymphoma Kinase

---
http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-ciblant-ALK-crizotinib-ceritinib
2016
false
false
false
France
French
guidelines for drug use
protein kinase inhibitors
crizotinib
carcinoma, non-small-cell lung
ceritinib
ceritinib
receptor Protein-Tyrosine kinases
antineoplastic agents
administration, oral
protein kinase inhibitors
ceritinib
Drug-Related side effects and adverse reactions
continuity of patient care
drug interactions
interdisciplinary communication
risk factors
drug monitoring
ceritinib
carcinoma, non-small-cell lung
ALK gene rearrangement positive
ALK protein, human
patients guideline
practice guideline
Tyrosine Kinase Inhibitors
pyrimidines
sulfones
pyrimidines
sulfones
pyrimidines
sulfones
receptor Protein-Tyrosine kinases
Crizotinib
Crizotinib
Crizotinib
Anaplastic Lymphoma Kinase

---
https://www.ema.europa.eu/medicines/human/EPAR/Zykadia
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
ceritinib
drug approval
europe
pyrimidines
pyrimidines
sulfones
sulfones
antineoplastic agents
antineoplastic agents
protein kinase inhibitors
protein kinase inhibitors
receptor Protein-Tyrosine kinases
adult
carcinoma, non-small-cell lung
carcinoma, non-small-cell lung
administration, oral
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
ceritinib
ceritinib
Tyrosine Kinase Inhibitors
Anaplastic Lymphoma Kinase

---
http://www.has-sante.fr/portail/jcms/c_2569228/fr/zykadia
http://www.has-sante.fr/portail/jcms/c_2569228/fr/zykadia-ceritinib-inhibiteur-de-tyrosine-kinase
2015
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
administration, oral
ceritinib
ceritinib
ceritinib
adult
Advanced Malignant Neoplasm
carcinoma, non-small-cell lung
carcinoma, non-small-cell lung
ALK gene rearrangement positive
insurance, health, reimbursement
protein kinase inhibitors
protein kinase inhibitors
antineoplastic agents
antineoplastic agents
protein-tyrosine kinases
survival analysis
guidelines for drug use
Tyrosine Kinase Inhibitors
pyrimidines
sulfones
pyrimidines
sulfones
receptor Protein-Tyrosine kinases
Anaplastic Lymphoma Kinase

---
http://www.cochrane.org/fr/CD007744/tolerabilite-des-inhibiteurs-selectifs-de-la-cyclo-oxygenase-2-cox-2-utilises-dans-le-traitement-des-manifestations-rhumatologiques-des-maladies-inflammatoires-de-lintestin
2014
false
false
false
France
United Kingdom
French
review of literature
cyclooxygenase 2 inhibitors
musculoskeletal diseases
french abstract
treatment outcome
Celecoxib
Celecoxib
celecoxib
etoricoxib
inflammatory bowel diseases
cyclooxygenase 2 inhibitors
pyridines
sulfones
pyridines
sulfones
Etoricoxib
Etoricoxib

---
http://www.cochrane.org/fr/CD004309
2013
United Kingdom
France
French
meta-analysis
administration, oral
treatment outcome
adult
acute disease
pain, postoperative
cyclooxygenase 2 inhibitors
pyridines
sulfones
french abstract
Etoricoxib

---
https://www.minerva-ebp.be/fr/article/621
false
false
minerva-ebm.be
Belgium
French
pyridines
cyclooxygenase inhibitors
sulfones
diclofenac
gastrointestinal diseases
osteoarthritis
arthritis, rheumatoid
anti-inflammatory agents, non-steroidal
critical appraisal or critical reading
comparative study

---
http://www.cochrane.org/fr/CD004604
2010
false
true
false
United Kingdom
France
lactones
sulfones
review of literature
french abstract
adult
pain, postoperative
rofecoxib
acute pain

---
http://www.cochrane.org/fr/CD003685
2010
false
true
false
United Kingdom
France
lactones
sulfones
treatment outcome
review of literature
french abstract
arthritis, rheumatoid
rofecoxib

---
http://www.has-sante.fr/portail/jcms/c_799056/arcoxia-30-et-60-mg-ct-5948
http://www.has-sante.fr/portail/jcms/c_825451/arcoxia-30-et-60-mg-etoricoxib-ains
2009
France
French
osteoarthritis
pyridines
sulfones
cyclooxygenase inhibitors
anti-inflammatory agents, non-steroidal
etoricoxib
evaluation of the transparency committee
guidelines for drug use
Etoricoxib

---
http://www.has-sante.fr/portail/jcms/c_825456/arcoxia-120-mg-etoricoxib-ains
http://www.has-sante.fr/portail/jcms/c_825455/synthese-d-avis-arcoxia-120-mg-ct-5948
http://www.has-sante.fr/portail/jcms/c_799058/arcoxia-120-mg-ct-5948
2009
France
French
pyridines
sulfones
cyclooxygenase inhibitors
anti-inflammatory agents, non-steroidal
gout
etoricoxib
evaluation of the transparency committee
guidelines for drug use
Etoricoxib

---
http://www.cochrane.org/fr/CD005115
2008
false
true
false
United Kingdom
France
lactones
sulfones
treatment outcome
meta-analysis
french abstract
rofecoxib
osteoarthritis

---
http://webprod.hc-sc.gc.ca/nhpid-bdipsn/monoReq.do?id=139&lang=fra
2007
Canada
French
dimethyl sulfoxide
dimethyl sulfoxide
sulfones
sulfones
administration, oral
anti-inflammatory agents
anti-inflammatory agents
osteoarthritis
pain
antiinflammatory and antirheumatic products
monograph pharmacy

---
https://www.minerva-ebp.be/fr/article/651
2007
false
false
minerva-ebm.be
Belgium
French
comparative study
arthritis, rheumatoid
anti-inflammatory agents, non-steroidal
diclofenac
sulfones
pyridines
cyclooxygenase 2 inhibitors
diclofenac
sulfones
pyridines
cyclooxygenase 2 inhibitors
anti-inflammatory agents, non-steroidal
cardiovascular diseases
critical appraisal or critical reading

---
https://rmlg.uliege.be/article/1089
2004
Belgium
French
pyridines
sulfones
cyclooxygenase inhibitors
journal article
Etoricoxib

---
https://www.cadth.ca/sites/default/files/pdf/108_No26_etoricoxib_edrug_f.pdf
2002
Canada
French
pyridines
sulfones
cyclooxygenase inhibitors
dysmenorrhea
pain
arthritis
etoricoxib
drug evaluation
comparative study

---
Nous contacter.
12/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.